Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Crager · SciRah

Researcher profile · Semantic Scholar

M. Crager

Share profile

M. Crager — researcher profile on SciRah

h-index: 16
Works: 60
Citations: 1,633

Most-cited papers

Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes.
A. Timmis, B. Chaitman, M. Crager
2006European Heart Journal193 citations
Semantic Scholar
Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis receiving aspirin.
S. Roth, N. Agrawal, M. Mahowald, H. Montoya +6 more
1989Archives of Internal Medicine140 citations
Semantic Scholar
Risk of recurrence and chemotherapy benefit for patients with node-negative, estrogen receptor-positive breast cancer: recurrence score alone and integrated with pathologic and clinical factors.
G. Tang, J. Cuzick, J. Costantino, M. Dowsett +5 more
2011Journal of Clinical Oncology130 citations Open access
Semantic Scholar
Cytomegalovirus (CMV) DNA Load Is an Independent Predictor of CMV Disease and Survival in Advanced AIDS
S. Spector, K. Hsia, M. Crager, Marshall Pilcher +2 more
1999Journal of Virology127 citations Open access
Semantic Scholar
A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Cytomegalovirus Peripheral Retinitis in Patients with AIDS
S. Spector, T. Weingeist, R. Pollard, D. Dieterich +11 more
1993Journal of Infectious Diseases118 citations
Semantic Scholar
Long-term safety of a novel antianginal agent in patients with severe chronic stable angina: the Ranolazine Open Label Experience (ROLE).
M. Koren, M. Crager, M. Sweeney
2007Journal of the American College of Cardiology114 citations Open access
Semantic Scholar
Development and Validation of a Tool Integrating the 21-Gene Recurrence Score and Clinical-Pathological Features to Individualize Prognosis and Prediction of Chemotherapy Benefit in Early Breast Cancer
J. Sparano, M. Crager, G. Tang, R. Gray +2 more
2020Journal of Clinical Oncology92 citations Open access
Semantic Scholar
21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer
C. Geyer, G. Tang, E. Mamounas, P. Rastogi +7 more
2018npj Breast Cancer89 citations Open access
Semantic Scholar
17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) Cohort.
D. Lin, Ying-Ye Zheng, Jesse K. McKenney, Marshall D. Brown +17 more
2020Journal of Clinical Oncology82 citations Open access
Semantic Scholar
Whole Transcriptome RNA-Seq Analysis of Breast Cancer Recurrence Risk Using Formalin-Fixed Paraffin-Embedded Tumor Tissue
D. Sinicropi, K. Qu, F. Collin, M. Crager +13 more
2012PLoS ONE78 citations Open access
Semantic Scholar
Analysis of covariance in parallel-group clinical trials with pretreatment baselines.
M. Crager
1987Biometrics73 citations
Semantic Scholar
Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies
E. Rakovitch, R. Gray, F. Baehner, R. Sutradhar +12 more
2018Breast Cancer Research and Treatment66 citations Open access
Semantic Scholar
Patient-specific Meta-analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate Score.
T. Brand, Nan Zhang, M. Crager, T. Maddala +11 more
2016Urology66 citations Open access
Semantic Scholar
Acetylcholine, aging and anatomy: differential effects in the hippocampus.
H. Haigler, L. Cahill, M. Crager, E. Charles
1986Brain Research43 citations
Semantic Scholar
GPS Assay Association With Long-Term Cancer Outcomes: Twenty-Year Risk of Distant Metastasis and Prostate Cancer–Specific Mortality
M. Brooks, L. Thomas, C. Magi-Galluzzi, Jian-Bo Li +5 more
2021JCO Precision Oncology28 citations Open access
Semantic Scholar
Safety and efficacy of extended-release ranolazine in patients aged 70 years or older with chronic stable angina pectoris.
M. Rich, M. Crager, C. McKay
2007American Journal of Geriatric Cardiology26 citations
Semantic Scholar
Clinical and Genomic Risk for Late Breast Cancer Recurrence and Survival
J. Sparano, M. Crager, R. Gray, G. Tang +18 more
2024NEJM Evidence15 citations Open access
Semantic Scholar
Abstract GS4-03: Validation of the clinical treatment score post 5 years (CTS5) in women with hormone receptor positive, HER2-negative, node-negative disease from the TAILORx study
I. Šestak, M. Crager, J. Cuzick, M. Dowsett +4 more
202013 citations Open access
Semantic Scholar
Title Patient-specific Meta-analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate
T. Brand, Nan Zhang, M. Crager, T. Maddala +10 more
201613 citations
Semantic Scholar
Recurrence risk of node-negative and ER-positive early-stage breast cancer patients by combining recurrence score, pathologic, and clinical information: A meta-analysis approach.
G. Tang, J. Cuzick, C. Wale, J. Costantino +5 more
201013 citations
Semantic Scholar
Gene identification using true discovery rate degree of association sets and estimates corrected for regression to the mean
M. Crager
2009Statistics in Medicine13 citations
Semantic Scholar
Population-based estimate for the correlation of the Oncotype Dx Breast Recurrence Score® result and Ki-67 IHC MIB-1 pharmDx in HR+, HER2−, node-positive early breast cancer
M. Crager, S. Wijayawardana, Aaron M. Gruver, A. Blacklock +3 more
2022Breast Cancer Research12 citations Open access
Semantic Scholar
Validating the Association of Adverse Pathology with Distant Metastasis and Prostate Cancer Mortality 20-Years After Radical Prostatectomy.
M. Brooks, L. Thomas, C. Magi-Galluzzi, Jian-Bo Li +6 more
2021Urologic oncology12 citations Open access
Semantic Scholar
Met-enkephalin, age and anatomy: a microiontophoretic study in the hippocampus.
H. Haigler, L. Cahill, M. Crager, E. Charles
1987Life Science10 citations
Semantic Scholar
Running average analysis of clinical trial ambulatory blood pressure data.
M. Crager, M. Reitman
1991Biometrics8 citations
Semantic Scholar
Patient-specific meta-analysis for risk assessment using multivariate proportional hazards regression
M. Crager, G. Tang
2014Journal of Applied Statistics7 citations Open access
Semantic Scholar
Adjusting for Covariates in Evaluating Markers for Selecting Treatment, With Application to Guiding Chemotherapy for Treating Estrogen-Receptor-Positive, Node-Positive Breast Cancer
H. Janes, Marshall D. Brown, M. Crager, Dave P. Miller +1 more
2017Contemporary Clinical Trials5 citations Open access
Semantic Scholar
Refined estimates of local recurrence risks and the impact of the DCIS score adjusting for clinico-pathological features: Meta-analysis of E5194 and Ontario DCIS cohort studies.
E. Rakovitch, R. Gray, F. Baehner, Dave P. Miller +12 more
20175 citations
Semantic Scholar
Generalizing the standardized hazard ratio to multivariate proportional hazards regression, with an application to clinical~genomic studies
M. Crager
20124 citations
Semantic Scholar
Misoprostol heals aspirin induced gastropathy in rheumatoid arthritis
S. Roth, N. Agrawal, M. Mahowald, H. Montoya +6 more
19874 citations
Semantic Scholar
Patient-specific meta-analysis of 12-gene colon cancer recurrence score validation studies for recurrence risk assessment after surgery with or without 5FU and oxaliplatin.
G. Yothers, A. Venook, E. Oki, D. Niedzwiecki +6 more
2022Journal of Gastrointestinal Oncology3 citations Open access
Semantic Scholar
Extensions of the absolute standardized hazard ratio and connections with measures of explained variation and variable importance
M. Crager
2020Lifetime Data Analysis3 citations
Semantic Scholar
Performance of the 17-gene genomic prostate score test in men with prostate cancer (PCa) managed with active surveillance (AS): Results from the Canary Prostate Active Surveillance Study (PASS).
D. Lin, Ying-Ye Zheng, Jesse K. McKenney, Marshall D. Brown +16 more
2019Journal of Clinical Oncology3 citations
Semantic Scholar
A 17-gene genomic prostate score (GPS) as a predictor of biochemical (BCR) and clinical recurrence (CR) in men with surgically treated intermediate- and high-risk prostate cancer (PCa).
E. Klein, Nan Zhang, M. Crager, T. Maddala +7 more
20163 citations
Semantic Scholar
Abstract S4-9: Comparing the Prediction of Chemotherapy Benefit in Patients with Node-Negative, ER-Positive Breast Cancer Using the Recurrence Score and a New Measure That Integrates Clinical and Pathologic Factors with the Recurrence Score
G. Tang, J. Costantino, M. Crager, S. Shak +1 more
20103 citations
Semantic Scholar
3.15: Safety of Regadenoson During Submaximal Exercise Testing: A Randomized, Double-Blind, Placebo- and Active-Controlled Trial (The RegEx Trial)
G. Thomas, Randall C. Thompson, M. Shah, M. Crager +4 more
20073 citations
Semantic Scholar
Abstract 3362: Effects of Ranolazine as Monotherapy and Combination Therapy on Rate Pressure Product at Rest and During Exercise: Results from the MARISA and CARISA trials
P. Stone, B. Chaitman, A. Koren, M. Crager
20063 citations
Semantic Scholar
Abstract 14: Analysis of tumor DNA in urine as a highly sensitive liquid biopsy for patients with non-muscle invasive bladder cancer (NMIBC)
M. Resnick, M. Lopatin, N. Shore, Po N. Lam +10 more
20162 citations
Semantic Scholar
Prospective Calculation of Identification Power for Individual Genes in Analyses Controlling the False Discovery Rate
M. Crager
2012Genetic Epidemiology2 citations
Semantic Scholar
Long-Term Safety of a Novel Antianginal Agent in Patients With Severe Chronic Stable Angina
J. Koreň, M. Crager, M. Sweeney
20072 citations
Semantic Scholar
Patient-specific meta-analysis of 3 validation studies of the 12-gene colon cancer recurrence score assay for recurrence risk assessment after surgery with or without 5FU and oxaliplatin.
G. Yothers, A. Venook, T. Yamanaka, Yan Lin +4 more
20211 citations
Semantic Scholar
Adverse pathology as a predictor of distant metastasis and prostate cancer mortality with 20-year follow up.
M. Brooks, L. Thomas, Cristina Magi-Galluzi, Jian-Bo Li +5 more
20211 citations
Semantic Scholar
Association of risk of clinical recurrence (CR) and prostate cancer death (PCD) with a 17-gene genomic prostate score (GPS) value <20.
P. Febbo, M. Crager, E. Burke, H. Lawrence +2 more
20171 citations
Semantic Scholar
Impact of the Recurrence Score (RS) result and mismatch repair status (MMR) on agreement between oncologists (MDs) for stage II colon cancer (CC) recurrence risk (RR) assessment: A novel clinical utility endpoint for prognostic markers.
R. K. Kelley, M. Lopatin, Jimmy Hwang, M. Crager +6 more
20131 citations
Semantic Scholar
Identification of prostate cancer-expressed microRNAs associated with clinical recurrence (cR) and prostate cancer-specific survival (PCSS) following radical prostatectomy (RP).
E. Klein, M. Kiefer, M. Crager, C. Magi-Galluzzi +7 more
2012Journal of Clinical Oncology1 citations
Semantic Scholar
Using the 21-gene recurrence score and the recently developed Recurrence Score-Clinical-Pathologic to assess recurrence risk in patients with node-negative, ER-positive early-stage breast cancer receiving aromatase inhibitor treatment alone.
M. Crager, G. Tang, S. Shak
2011Journal of Clinical Oncology1 citations
Semantic Scholar
Abstract PO1-02-02: Update of RSClin with extended TAILORx follow-up and development and validation of a new tool for risk of late distant recurrence
J. Sparano, M. Crager, R. Gray, G. Tang +6 more
2024Cancer Research0 citations
Semantic Scholar
Abstract PD15-05: Assessment of estrogen receptor (ESR1) mRNA expression for prediction of extended aromatase inhibitor benefit in HR-positive breast cancer using NRG Oncology/NSABP B-42
E. Mamounas, H. Bandos, P. Rastogi, M. Crager +15 more
2022Cancer Research0 citations
Semantic Scholar
Reply to K. Ando et al.
J. Sparano, M. Crager, G. Tang, R. Gray +2 more
2021Journal of Clinical Oncology0 citations Open access
Semantic Scholar
Abstract GS4-10: Development and validation of a tool integrating the 21-gene recurrence score and clinicopathlogic features to individualize prognosis for distant recurrence and prediction of absolute chemotherapy benefit in early breast cancer
J. Sparano, M. Crager, G. Tang, R. Gray +2 more
20210 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Shak×15
Invite
S. Shak — researcher profile on SciRah
G. Tang×11
Invite
G. Tang — researcher profile on SciRah
F. Baehner×10
Invite
F. Baehner — researcher profile on SciRah
J. Sparano×6
Invite
J. Sparano — researcher profile on SciRah

×6

Invite

R. Gray — researcher profile on SciRah

Invite

E. Klein — researcher profile on SciRah

Invite

R. Lu — researcher profile on SciRah

Invite

P. Febbo — researcher profile on SciRah

J. Costantino×4

Invite

J. Costantino — researcher profile on SciRah

Invite

N. Wolmark — researcher profile on SciRah

Invite

H. Lawrence — researcher profile on SciRah

C. Magi-Galluzzi×4

Invite

C. Magi-Galluzzi — researcher profile on SciRah